• Je něco špatně v tomto záznamu ?

An Assay of Selected Serum Amino Acids in Patients with Type 2 Diabetes Mellitus

P. Drábková, J. Šanderová, J. Kovařík, R. kanďár,

. 2015 ; 24 (3) : 447-51.

Jazyk angličtina Země Polsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc16000011

BACKGROUND: Amino acids are the building blocks of proteins. In case of insulin resistance, which is typical for type 2 diabetes mellitus (T2DM), proteolysis is increased and protein synthesis is decreased; therefore, we can observe changes in the levels of amino acids in diabetics vs. non-diabetics. OBJECTIVES: The aim of this study was to find differences in the levels of selected amino acids between patients with diabetes (type 2) and a control group. MATERIAL AND METHODS: Amino acids were derivatized with naphthalene-2,3-dicarboxaldehyde in the presence of potassium cyanide to form fluorescent 1-cyanobenz(f)isoindole product. Amino acids derivatives were measured using a high-performance liquid chromatography with fluorescence detection. The serum levels of glucose were determined using an automatic biochemistry analyzer, glycated hemoglobin HbA1c was measured by cation exchange chromatography. RESULTS: A total of 19 serum amino acids in T2DM patients and non-diabetics were measured. There were 9 amino acids, which were significantly different in these groups (p<0.05). Significantly decreased levels of arginine, asparagine, glycine, serine, threonine and significantly increased levels of alanine, isoleucine, leucine, valine in diabetics were found. CONCLUSIONS: Significant difference in metabolism of amino acids between diabetics and non-diabetics were observed. The altered levels of amino acids in diabetic patients could be a suitable predictor of diabetes.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16000011
003      
CZ-PrNML
005      
20200121083425.0
007      
ta
008      
160108s2015 pl f 000 0|eng||
009      
AR
024    7_
$a 10.17219/acem/29223 $2 doi
035    __
$a (PubMed)26467133
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a pl
100    1_
$a Drábková, Petra $u Department of Biological and Biochemical Sciences, Faculty of Chemical Technology, University of Pardubice, Czech Republic.
245    13
$a An Assay of Selected Serum Amino Acids in Patients with Type 2 Diabetes Mellitus / $c P. Drábková, J. Šanderová, J. Kovařík, R. kanďár,
520    9_
$a BACKGROUND: Amino acids are the building blocks of proteins. In case of insulin resistance, which is typical for type 2 diabetes mellitus (T2DM), proteolysis is increased and protein synthesis is decreased; therefore, we can observe changes in the levels of amino acids in diabetics vs. non-diabetics. OBJECTIVES: The aim of this study was to find differences in the levels of selected amino acids between patients with diabetes (type 2) and a control group. MATERIAL AND METHODS: Amino acids were derivatized with naphthalene-2,3-dicarboxaldehyde in the presence of potassium cyanide to form fluorescent 1-cyanobenz(f)isoindole product. Amino acids derivatives were measured using a high-performance liquid chromatography with fluorescence detection. The serum levels of glucose were determined using an automatic biochemistry analyzer, glycated hemoglobin HbA1c was measured by cation exchange chromatography. RESULTS: A total of 19 serum amino acids in T2DM patients and non-diabetics were measured. There were 9 amino acids, which were significantly different in these groups (p<0.05). Significantly decreased levels of arginine, asparagine, glycine, serine, threonine and significantly increased levels of alanine, isoleucine, leucine, valine in diabetics were found. CONCLUSIONS: Significant difference in metabolism of amino acids between diabetics and non-diabetics were observed. The altered levels of amino acids in diabetic patients could be a suitable predictor of diabetes.
650    _2
$a senioři $7 D000368
650    _2
$a aminokyseliny $x krev $7 D000596
650    _2
$a laboratorní automatizace $7 D057205
650    _2
$a biologické markery $x krev $7 D015415
650    _2
$a krevní glukóza $x analýza $7 D001786
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a vysokoúčinná kapalinová chromatografie $7 D002851
650    _2
$a chromatografie iontoměničová $7 D002852
650    _2
$a diabetes mellitus 2. typu $x krev $x diagnóza $7 D003924
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a glykovaný hemoglobin $x analýza $7 D006442
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a fluorescenční spektrometrie $7 D013050
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Šanderová, Jana $u Department of Biological and Biochemical Sciences, Faculty of Chemical Technology, University of Pardubice, Czech Republic.
700    1_
$a Kovařík, Jakub $u Department of Clinical Biochemistry and Diagnostics, Faculty of Chemical Technology, Regional Hospital Pardubice, Czech Republic.
700    1_
$a kanďár, Roman $u Department of Biological and Biochemical Sciences, Faculty of Chemical Technology, University of Pardubice, Czech Republic.
773    0_
$w MED00187101 $t Advances in clinical and experimental medicine official organ Wroclaw Medical University $x 1899-5276 $g Roč. 24, č. 3 (2015), s. 447-51
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26467133 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160108 $b ABA008
991    __
$a 20200121083802 $b ABA008
999    __
$a ok $b bmc $g 1102292 $s 924217
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 24 $c 3 $d 447-51 $i 1899-5276 $m Advances in clinical and experimental medicine $n Adv Clin Exp Med $x MED00187101
LZP    __
$a Pubmed-20160108

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace